How to Launch a TRT Brand as an Entrepreneur

Testosterone replacement therapy is one of the highest-retention, highest-lifetime-value programs in cash-pay medicine. TRT patients start therapy, feel better, and almost never voluntarily stop. For an Entrepreneur building a recurring-revenue health brand, few programs offer a better combination of strong demand, clear clinical value, and durable monthly revenue.

The barrier most non-clinical Entrepreneurs assume exists — needing a medical license to operate a TRT brand — does not exist in the way they imagine. You can build, own, and scale a TRT brand without being a doctor. The clinical layer is separable from the business layer, and purpose-built platforms make that separation clean and compliant.

This guide covers everything a non-clinical Entrepreneur or Creator needs to know before launching a TRT brand: the market opportunity, how compounded testosterone works, how the business model functions without a medical license, what you need to launch, the economics, and the regulatory guardrails you must operate within.

The TRT Market Opportunity

The demand for testosterone therapy is large, underpenetrated, and growing.

An estimated 4 to 5 million American men have symptomatic testosterone deficiency, according to the American Urological Association. Only about 5% to 10% of hypogonadal men are currently receiving treatment. That gap represents tens of millions of men who are symptomatic, aware that treatment exists, and not getting it through traditional healthcare.

The reasons for undertreatment are structural, not clinical:

• Primary care physicians rarely screen for low testosterone proactively
• Insurance coverage is inconsistent and prior authorization is burdensome
• The stigma around testosterone use has decreased substantially but access has not kept pace
• Men aged 30 to 55 are increasingly health-literate and willing to pay cash for outcomes

Direct-to-consumer TRT brands like Hims, Maximus, and Fountain TRT have proven this market converts well through digital channels. They have also priced their programs at levels ($100 to $200 per month) that leave meaningful room for a well-differentiated brand to compete on quality, personalization, or community rather than price alone.

The performance, longevity, and men’s optimization communities are also driving a new wave of TRT demand among younger men (late 20s and 30s) who are interested in hormonal optimization rather than traditional treatment of deficiency. This segment tends to be high-income, highly engaged, and a strong fit for a premium-positioned brand.

How Compounded Testosterone Works

Why Compounded Testosterone Exists

Brand-name testosterone formulations include Androgel (topical gel), Testim (gel), and several FDA-approved injectables. These are effective but either expensive at cash-pay rates or less flexible than what a personalized program requires.

Compounding pharmacies prepare testosterone using pharmaceutical-grade APIs at custom concentrations, in formulations and dosages not available through brand-name products. Compounded testosterone cypionate or enanthate for injection, and compounded testosterone cream at custom concentrations, are the foundation of virtually every cash-pay TRT program.

Compounded testosterone is legal when prescribed by a licensed Provider with an active DEA registration and dispensed by an appropriately licensed compounding pharmacy.

Common TRT Formulations

Testosterone Cypionate (Injectable)

The dominant formulation in cash-pay TRT. Subcutaneous or intramuscular injection, typically once or twice weekly. Produces stable, predictable blood levels when dosed correctly. Compounded monthly cost: $30 to $60.

Testosterone Enanthate (Injectable)

Nearly identical pharmacokinetics to cypionate. Some patients and Providers prefer it; the practical differences are minimal. Compounded monthly cost: $30 to $60.

Testosterone Cream (Topical)

Applied daily to thin-skinned areas (inner arm, inner thigh, or scrotal skin). Good option for patients who prefer not to inject. Scrotal application achieves higher absorption and is increasingly used in protocols that also aim to maintain DHT levels. Compounded monthly cost: $40 to $80.

Adjunct Medications

Many TRT protocols include one or more adjunct medications:

• Anastrozole: An aromatase inhibitor used to manage estrogen levels that rise in response to testosterone. Prescribed at low doses (0.25 to 0.5 mg twice weekly) for patients who show high estradiol or symptoms of estrogen excess.
• HCG (Human Chorionic Gonadotropin): Used to maintain testicular function and fertility in men on TRT. Important for patients who want to preserve fertility options. Compounded or available as brand-name Pregnyl.
• Enclomiphene: An estrogen receptor antagonist sometimes used as an alternative to HCG for testicular stimulation, or as a standalone testosterone optimization tool for men who want to avoid exogenous testosterone.

Offering adjunct medications as optional add-ons expands your revenue per patient and increases the clinical comprehensiveness of your program, which reduces churn.

The Business Model: How a TRT Brand Makes Money

A TRT brand is a subscription healthcare business. Revenue comes from monthly program fees paid by patients on ongoing therapy.

The model:

1. Acquire the patient through paid advertising, organic search, referral, community, or influencer partnerships
2. Patient completes an Intake: health history, symptom questionnaire, lab submission
3. Eligibility Screen evaluates the Intake against contraindications before a Provider sees it
4. Provider Review: a licensed Provider reviews the Case, orders additional labs if needed, and issues a prescription if appropriate
5. Pharmacy fulfillment: a compounding pharmacy prepares the testosterone and ships directly to the patient
6. Monthly subscription: the patient pays a recurring fee for ongoing medication, Provider access, and monitoring
7. Lab monitoring and renewal: labs are repeated at intervals; the Provider reviews and renews or adjusts the prescription

The business earns margin on the spread between what it costs to operate the program per patient (medication, Provider consult cost, platform, support) and what the patient pays each month. Because TRT patients stay on therapy for years, the margin compounds across the patient lifetime.

The Entrepreneur Advantage Over a Clinic

A traditional clinic adding TRT is constrained by geography, physical space, and the clinical capacity of employed providers. An Entrepreneur launching a telehealth TRT brand has none of those constraints:

• Serve patients in all 50 states from day one (with a 50-state Provider Network)
• No physical overhead
• Scale patient volume without proportional increases in operational cost
• Build a brand that can be differentiated on community, content, and positioning rather than just clinical credentials

The Entrepreneur model is fundamentally a media and brand business that happens to deliver a medical program. The best non-clinical TRT brands win on trust, community, and content — not on the clinical credentials of their medical team.

Brand Positioning Opportunities

The TRT market has room for distinct positioning strategies:

• Performance: Athletes, lifters, and body composition-focused men who see TRT as a performance tool
• Longevity: Men in their 40s and 50s focused on healthy aging, cognitive performance, and metabolic health
• Men’s optimization: Broader men’s health brand covering TRT, peptides, GLP-1, and sexual health in one program
• Discretion and privacy: Men who want a high-quality experience without the clinical atmosphere of a traditional men’s clinic
• Community: Brands built around content, creators, or communities where TRT is one of several health topics

Picking one of these lanes and owning it is more valuable than trying to be all things to all TRT patients.

What You Need to Launch

1. A Clinical Platform

You need software to manage patient Intake, Eligibility Screening, Provider workflows, prescription routing, and ongoing monitoring. The platform must support controlled substance prescribing (EPCS integration) and maintain HIPAA-compliant records. Building this from scratch is expensive and requires significant compliance work. White-label platforms designed for this use case come pre-built with the clinical and operational infrastructure already in place.

2. A Provider Network

Testosterone is a Schedule III controlled substance. Every prescription must be issued by a Provider with an active DEA registration. If you are not a clinician, you need either a contracted Provider or access to a platform-provided Provider Network. A 50-state Provider Network removes the single biggest operational constraint for non-clinical Entrepreneurs: finding, contracting, and managing prescribers.

3. A DEA-Registered Compounding Pharmacy

Your pharmacy partner must be DEA-registered to dispense Schedule III controlled substances, licensed in the states where your patients are located, and capable of producing sterile injectable formulations and topical creams. Quality markers to evaluate:

• Sterility and potency testing with third-party certificates of analysis
• Electronic prescribing integration (EPCS-capable)
• Direct-to-patient shipping with temperature controls
• Track record in hormone compounding specifically

4. Patient Acquisition

Most TRT brands start with paid Meta and Google advertising. The typical patient journey starts with a symptom search or a social ad, lands on a brand page, and converts through a streamlined Intake process. Key benchmarks to understand before you spend:

• Patient acquisition cost (PAC): $100 to $250 is achievable with well-optimized creative
• Intake-to-approval rate: depends on your Eligibility Screen and population, typically 50% to 70%
• Approval-to-subscription rate: depends on onboarding experience, typically 60% to 80%

SEO, content marketing, and influencer partnerships reduce average PAC significantly over time. Many of the most efficient TRT brands are built on communities and content that generate warm, high-converting traffic.

Economics: Revenue Model and Patient LTV

Sample Program Economics

Assume a program price of $199 per month, which is competitive for a compounded testosterone program that includes the medication, Provider access, lab review, and ongoing monitoring.

At a monthly churn rate of 4%, average patient lifetime is approximately 25 months. At $199 per month, average patient lifetime value is approximately $4,975.

At $175 patient acquisition cost, payback period is under two months and return on acquisition spend exceeds 28x over the patient lifetime.

Scale Economics

These projections assume a single $199/month plan with 4% monthly churn. Real programs include upsells (adjunct medications, lab panels, premium tiers) that increase average revenue per patient beyond the base program price.

What Differentiates Top-Performing TRT Brands

The economics of TRT are good for almost any competently run program. The programs that build disproportionate enterprise value do three things well:

1. They reduce early churn. The dropout window is weeks 3 to 8, before patients feel the full effects. Proactive check-ins, clear timeline expectations, and responsive provider access close this window.
2. They cross-sell intelligently. TRT patients are excellent candidates for peptide therapy (BPC-157, CJC-1295/Ipamorelin), GLP-1 weight loss, and sexual health programs. A patient on multiple programs is significantly less likely to cancel any one of them.
3. They build community or content. TRT brands with active communities or educational content channels acquire patients at lower cost and retain them at higher rates because the brand relationship extends beyond the monthly shipment.

Regulatory Landscape

DEA and Controlled Substance Requirements

Testosterone is a Schedule III controlled substance. This does not prevent a non-clinical Entrepreneur from owning the business. It does mean your clinical operations must comply with DEA requirements:

• All Providers must hold active DEA registration
• Prescriptions must use Electronic Prescribing for Controlled Substances (EPCS) where required by state law
• Prescription records must be maintained per DEA requirements
• The compounding pharmacy must be DEA-registered

These requirements are handled at the clinical and pharmacy layer. Your platform and prescribing network should manage DEA compliance operationally so you do not need to build expertise in it from scratch.

Telehealth Prescribing for Testosterone

The Ryan Haight Act generally requires a prior in-person examination before prescribing controlled substances via telehealth. However, the DEA has proposed permanent special registration rules for telehealth prescribing of controlled substances. State-specific rules also create variation. Some states have their own telehealth prescribing allowances; others are more restrictive.

Your prescribing network should maintain current state-by-state compliance guidance and ensure Providers are operating within applicable rules. For a deeper review, read our telehealth prescribing guide.

HIPAA

Your platform handles protected health information. All technology and pharmacy partners must sign Business Associate Agreements. Avoid advertising pixels on Intake pages that could transmit PHI to ad platforms. For a full overview, read our HIPAA compliance guide for cash-pay programs.

FTC and Advertising

Testosterone advertising is subject to FTC guidelines on health claims. Do not make unsubstantiated outcome claims. Reference peer-reviewed clinical evidence when supporting efficacy claims. The FTC has increased scrutiny of supplement and health brand advertising; review their health products compliance guidance before running paid media.

The Difference Between an Entrepreneur TRT Brand and a Clinic

The most common misunderstanding non-clinical Entrepreneurs have is that launching a TRT brand means operating like a clinic. It does not.

A clinic’s value is in its clinical relationships, patient referrals, and physical presence. An Entrepreneur TRT brand’s value is in its brand, its community, its marketing infrastructure, and its patient acquisition system.

The clinical layer — Provider Review, prescription issuance, DEA compliance — is the same regardless of whether the operator is a clinic or a non-clinical brand. What changes is everything else: how patients find you, why they trust you, what experience they have, and how the brand grows over time.

Non-clinical TRT brands that compete successfully do so on distribution and positioning, not on clinical credentials. They have better content, stronger communities, cleaner customer experiences, and more efficient marketing operations than most traditional clinics.

Launch Checklist

1. Choose your brand positioning (performance, longevity, optimization, privacy, community)
2. Select a white-label clinical platform with Provider Network and pharmacy integration
3. Confirm 50-state Provider Network coverage for controlled substance prescribing
4. Confirm pharmacy partner is DEA-registered and capable of compounded testosterone
5. Build your brand identity (name, visual identity, website, positioning)
6. Configure patient Intake forms (symptom assessment, medical history, contraindications)
7. Establish lab ordering workflow (patient-directed or integrated)
8. Set pricing and program tiers (base program, adjunct add-ons, premium tier)
9. Create patient onboarding communication (expectations, timeline, protocol overview)
10. Launch patient acquisition campaigns (Meta, Google, and one content or community channel)

How Karpa Health Helps You Launch

Karpa Health provides the complete infrastructure for launching and scaling a TRT brand as a non-clinical Entrepreneur. The Platform includes white-label patient Intake, a 50-state Provider Network with DEA-registered Providers, integrated Pharmacy Integration with vetted compounding partners, and the practice management tools needed to run a compliant, scalable program.

You bring the brand, the positioning, and the patients. Karpa Health provides the clinical and operational backbone.

Explore the entrepreneur program to see how non-clinical operators launch on the Platform, or review the how to start a TRT clinic guide if you are a Clinic Owner adding TRT to an existing practice.

For related context, read our guides on how to launch a telehealth clinic without a medical license, the medical director vs Provider Network decision, and the cash-pay revenue model for GLP-1 and peptide programs.

Start your TRT brand if you are ready to launch with Karpa Health.